Indeed, enhanced activity of IMiDs could lower the threshold concentrations of ligands expressed on tumor cells needed for optimal activation of several activating receptors (e.g. CD16 or NKG2D), by increasing nanoscale rearrangements in cortical actin at the NK-target cell immunologic synapse, as already described in52. Here, KLRK1 is linked to neoplasm.